Oral Arsenic Trioxide and Itraconazole for the Treatment of Patients With Advanced Basal Cell Carcinoma
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2016
At a glance
- Drugs Arsenic trioxide (Primary) ; Itraconazole (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 09 Dec 2016 Planned End Date changed from 1 Feb 2018 to 1 Nov 2019.
- 09 Dec 2016 Planned primary completion date changed from 1 Sep 2017 to 1 Jun 2018.